We believe that these types of exclusions are also recognized by theindustry in which we operate as relevant in

We believe that these types of exclusions are also recognized by theindustry in which we operate as relevant in computing Adjusted EPS as asupplementary non-GAAP financial measure widely used by financial analysts andothers in our industry to meaningfully evaluate a company`s operatingperformance. Business Segments -The Company operates in five primary business segments: NorthAmerica / Home Medical Equipment (“HME”), Invacare Supply Group, InstitutionalProducts Group, Europe and Asia/Pacific. The five reportable segments representoperating groups, which offer products to different geographic regions.Intersegment revenue for reportable segments was $25,450,000 and $24,955,000 forthe three months ended March 31, 2009 and 2008, respectively. Effective January1, 2009, segment earnings before income taxes have been changed to reflectchanges in how management currently views earnings before income taxes for thesegments. Specifically, Asia/Pacific earnings before income taxes now includesprofit on intercompany sales with an offsetting adjustment to All Other andNorth America/HME now includes a greater allocation of interest expense with anoffsetting reduction for Europe. The prior year has been reclassified to conformto the current year presentation. Management believes that this financial measureprovides meaningful information for evaluating the overall financial performanceof the Company and its ability to repay debt or make future investments(including, for example, acquisitions).

Invacare CorporationInvestor Inquiries:Robert Gudbranson, 440-329-6111 Copyright Business Wire 2009. Company Increases Diluted EPS from Continuing Operations Guidance for FiscalYear 2009 to between $3.18 and $3.30VALLEY FORGE, Pa.–(Business Wire)–AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year2009 second quarter ended March 31, 2009, diluted earnings per share fromcontinuing operations were a record $0.95, a 17 percent increase. The Companyalso increased its fiscal year 2009 diluted earnings per share from continuingoperations expectations to a range of $3.18 to $3.30, a 10 percent to 14 percentincrease over last fiscal year`s $2.89. The previous guidance for fiscal year2009 was $3.08 to $3.25 for diluted earnings per share from continuingoperations. Fiscal Second Quarter Highlights* Record diluted earnings per share from continuing operations of $0.95, a 17percent increase * Revenue of $17.3 billion, down 2.5 percent.

* Operating expense dollars, excluding facility consolidations, employeeseverance and other charges, down from the prior year`s second quarter * Operating margin of 1.43 percent, up 11 basis points * Cash flows from operations of $337 million * $92 million of share repurchases. * Ratings upgrade to BBB+ from Standard & Poor`s.Fiscal First Six Months Highlights* Record diluted earnings per share from continuing operations of $1.67, a 14percent increase * Revenue of $34.7 billion, down 1.1 percent. * Operating expense dollars, excluding facility consolidations, employeeseverance and other charges, down from the prior year`s first six months * Operating margin of 1.29 percent, up 7 basis points. * $180 million of share repurchases.”Our outstanding operating results in the March quarter reflected the continuedstrong performance of our two growth drivers, generic drug distribution and ourspecialty distribution and related services business, as well as continued costdiscipline,” said R. David Yost, AmerisourceBergen`s President and ChiefExecutive Officer. “Revenue in the quarter was down 2.5 percent, but would haveincreased 3 percent when adjusted for one less business day than the previousyear`s second quarter and the negative impact of the July 1, 2008 loss of thedirect-to-warehouse business of a large retail drug chain.

“The rise in profitability was driven by a double-digit increase in generic drugsales; excellent performance in our higher-margin specialty business; goodperformance under our fee-for-service contracts with manufacturers; and solidexpense control. Our receivable days were again down in the quarter; our balancesheet remains strong; and we have good financial flexibility.” Summary of Quarterly Results* Revenue: In the second quarter of fiscal 2009, revenue was $17.3 billion, down2.5 percent compared to the same quarter in the previous fiscal year, dueprimarily to a 4 percent decrease in AmerisourceBergen Drug Corporation revenueand one less business day than in the prior-year`s second quarter, offset inpart by an 8 percent increase in AmerisourceBergen Specialty Group revenue. DrugCorporation revenue in the fiscal 2009 second quarter was down due primarily tothe loss last July of the direct-to-warehouse business. * Operating Expenses: For the second quarter of fiscal 2009, operating expenseswere $304.2 million compared with $302.3 million in the prior fiscal year`ssecond quarter, including charges for facility consolidations, employeeseverance and other of $4.3 million and $1.4 million in the second quarters offiscal 2009 and 2008, respectively. * Operating Income: In the fiscal 2009 second quarter, operating incomeincreased 6 percent to $248.3 million, due primarily to increased gross profitand disciplined expense management.